Senior Product Manager, BillionToOne
Oncology
$265k
OTE
$168.3-204k
BASE
+ Equity + Corporate Bonus Program
More information about location
3+ days a week in office (Menlo Park, CA)
Precision diagnostics for disease detection
Be an early applicant
Precision diagnostics for disease detection
201-500 employees
Be an early applicant
$265k
OTE
$168.3-204k
BASE
+ Equity + Corporate Bonus Program
More information about location
3+ days a week in office (Menlo Park, CA)
201-500 employees
Company mission
To make molecular diagnostics more accurate, efficient, and accessible.
Role
Who you are
- The ideal candidate is entrepreneurial, thrives in a fast-paced, dynamic environment, and can navigate the complexities of scaling innovative products in a competitive market
- 2-3 years of product management experience with demonstrated end-to-end ownership of complex product lines. Alternatively, 2-3 years of business consulting experience in biotech field with demonstrated end-to-end ownership would suffice
- GM-like mindset with strategic vision and hands-on execution skills
- Excellent and leading and collaborating with cross-functional teams
- Strong background in product launch strategy, go-to-market execution, and program management
- On-site position (onsite 3 days/week; relocation to SF Bay Area required)
What the job involves
- We are seeking a highly driven leader for one of the most critical and high-impact roles at BillionToOne: Senior/Principal Product Manager, Oncology
- In this role, you will have the end-to-end product ownership for Northstar Select and Response, our liquid biopsy assays for therapy selection and response monitoring, from product concept and requirements gathering to assay launches
- You will lead new assay development, drive product enhancements, and collaborate with diverse teams, including R&D, clinical, and engineering
- You’ll be responsible for ensuring our oncology products not only meet market demands but set the standard in the industry
- This role is an hybrid (onsite 3 days/week) position and reports directly to the Chief Product Officer
- Extreme Ownership: Own the oncology product line from top to bottom, ensuring long-term strategic success while handling day-to-day tactical responsibilities
- Voice of Customer: Be the company’s leading expert on user needs, market trends, and how BillionToOne’s technology can solve critical problems in oncology diagnostics
- Product Launch & Execution: Lead product launch strategies, overseeing every element from assay development to software apps, regulatory constraints, and customer experience
- Cross Funtional Management: Manage and inspire a cross-functional team of R&D, clinical, engineering, and commercial experts, aligning their efforts towards the product’s success
- Drive Continuous Improvement: Monitor product performance, user feedback, and market shifts, making data-driven decisions to enhance product offerings and maintain leadership in the market
Our take
BillionToOne is a precision diagnostics company. Its proprietary molecular counting platform (Quantitative Counting Templates) accurately counts DNA molecules at the single-count level, which has the ability to significantly improve disease detection. While initially focused on prenatal screening and oncological liquid biopsies, the company’s QTC technology is highly scalable and has the ability to make vast improvements to a range of disease detection verticals.
The company’s funding efforts will enable it to focus on further development and commercialization of its noninvasive prenatal screening test and oncology products. However, it will need to maintain a strategic outlook, prioritizing areas with higher testing frequencies in order to provide maximum patient benefit, while balancing test development costs.
BillionToOne has an important role to play in improving healthcare equity. As more promising peer-reviewed research studies are conducted and providers have increased confidence in the company’s tests, BillionToOne has significant growth potential.
Freddie
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 4 rounds)
Dec 2022
$5m
SERIES B
Mar 2022
$21m
SERIES B
Total funding: $43.3m
Company benefits
- Suite of benefit plans
- Paid Medical, Pregnancy, Parental and Family Leaves
- Retirement savings program with Company contribution
- Generous equity package
- Free daily on-site lunches provided from top eateries
- Latest and greatest hardware (laptop, lab equipment, facilities)
- Free on-site EV charging (compatible with all EVs, including Tesla!)
- Working with a team of ‘rockstars’ who bring out the best in everyone
- The ability to indirectly or directly change the lives of hundreds of thousand patients
- Open, transparent culture that includes weekly Town Hall meetings
Company values
- Profoundly Impactful
- Creative & Innovative
- Internally Motivated & Passionate
- Rational & Deliberate
- Kindly Inquisitive & Collaborative
- Patient-Centered
Company HQ
Menlo Park, CA
Articles
Leadership
Oguzhan Atay, PhD
(CEO)Former Graduate Fellow at Stanford University (Department of Biology). They also spent time as a Researcher at the University of Oxford.
David Tsao
(CTO)Former Technical Staff Member at Groupon and Software Engineer at Adku. They also worked as an Engineering Intern at Northrop Grumman Aerospace Systems.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 7 more jobs at BillionToOne